Financhill
Back

Verisk Analytics Vs. Tonix Pharmaceuticals Holding Industry Stock Comparison

Buy
61

VRSK
Verisk Analytics

Last Price:
$291.59
Seasonality Move:
5.59%
Buy
58

TNXP
Tonix Pharmaceuticals Holding

Last Price:
$27.83
Seasonality Move:
-16.53%
Buy
61
Verisk Analytics (VRSK) is a Buy

Is Verisk Analytics a Buy, Sell or Hold?

  • The current Verisk Analytics [VRSK] share price is $287.76. The Score for VRSK is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Tonix Pharmaceuticals Holding (TNXP) is a Buy

Is Tonix Pharmaceuticals Holding a Buy, Sell or Hold?

  • The current Tonix Pharmaceuticals Holding [TNXP] share price is $29.77. The Score for TNXP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TNXP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRSK Stock Price Chart

What is Verisk Analytics's stock price today?

  • The Verisk Analytics share price today is $287.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing buying pressure, which is a positive indicator for future bullish movement.

TNXP Stock Price Chart

What is Tonix Pharmaceuticals Holding's stock price today?

  • The Tonix Pharmaceuticals Holding share price today is $29.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNXP is experiencing slight buying pressure.

VRSK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.07 Sell
Relative Strength Index (14 RSI): 45.86 Sell
Chaikin Money Flow: 931672 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (287.74 - 297.16) Sell
Bollinger Bands (100): (276.54 - 293.24) Buy

TNXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.36 Buy
Relative Strength Index (14 RSI): 70.3 Buy
Chaikin Money Flow: 425756 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.68 - 20.18) Buy
Bollinger Bands (100): (10.27 - 32.83) Buy

VRSK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 288.03 Sell
20-day SMA: 292.03 Sell
50-day SMA: 288.38 Sell
200-day SMA: 277.14 Buy
8-day EMA: 288.12 Sell
20-day EMA: 290.12 Sell
50-day EMA: 288.67 Sell
200-day EMA: 275.12 Buy

TNXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.21 Buy
20-day SMA: 14.83 Buy
50-day SMA: 19.56 Buy
200-day SMA: 42.15 Sell
8-day EMA: 22.54 Buy
20-day EMA: 18.22 Buy
50-day EMA: 19.22 Buy
200-day EMA: 547.39 Sell

Verisk Analytics Earnings Growth & VRSK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.

Tonix Pharmaceuticals Holding Earnings Growth & TNXP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $733.01 per share, an increase next quarter of $0.83 per share, a decrease this year of $8.50 per share, and an increase next year of $7.22 per share.

Verisk Analytics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Tonix Pharmaceuticals Holding Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):